You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Valneva begins COVID-19 boosters in vaccine trial

France-based Valneva has started booster vaccinations with its inactivated COVID-19 vaccine candidate VLA2001, following on from the Phase I/II VLA2001-201 trial.